Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04904055 · ClinicalTrials.gov registry record
Evaluating the Impact of a Value-based Prescription Drug Formulary
A clinical trial of Value-Based Health Insurance, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 36,333
- Enrollment target
- 1
- Study location
NCT04904055: Completed study of Value-Based Health Insurance, sponsored by Kaiser Permanente.
NCT04904055 is a study of Value-Based Health Insurance that has completed, run by Kaiser Permanente. The registered enrollment target is 36,333 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04904055, a study of Value-Based Health Insurance, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 36,333 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.
Primary Outcome
Impact of value-based formulary on patient out-of-pocket plus health plan spending on prescription drugs per member per month
Conditions Studied
Interventions
- OTHER Value-based Formulary
Study Locations (1)
Washington
- Kaiser Permanente - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36,333 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2019-12-31 |
What the finished NCT04904055 record still lists
NCT04904055 is an observational study that tracks outcomes without assigning an intervention. Its 36,333 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Value-Based Health Insurance appearing as the primary indexed condition, and to 1 intervention - of which Value-based Formulary is the first listed.
NCT04904055 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04904055 about?
NCT04904055 is a clinical study titled "Evaluating the Impact of a Value-based Prescription Drug Formulary". The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.
What is the current status of trial NCT04904055?
This trial is currently completed. The enrollment target is 36,333 participants. The study started on 2015-01-01. Estimated completion is 2019-12-31.
What conditions does trial NCT04904055 study?
This clinical trial studies the following conditions: Value-Based Health Insurance.
What interventions are being tested in trial NCT04904055?
The interventions under investigation include: Value-based Formulary (OTHER).
Who is sponsoring clinical trial NCT04904055?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04904055 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07150923 · 36,503 participants · NA
Supraglottic Airway for Resuscitation Trial
- NCT03262259 · 36,000 participants · NA
Evaluation of Global Smart Drinking Goals Initiative
- NCT05796505 · 37,122 participants · NA
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
- NCT02225301 · 35,000 participants · NA
iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI